We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Temporal Comparison Software Helps Detect Potential Lung Tumors Earlier

By MedImaging International staff writers
Posted on 18 Jan 2012
Print article
New X-ray software electronically compares current and earlier chest radiographic images and helps identify nodules that may be early-stage lung cancer, when there are more treatment options.

Riverain Technologies (Dayton, OH, USA) reported that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Temporal Comparison software. The first-of-its-kind technology targets differences between current and prior chest X-rays of the same patient, drawing attention to what may be an emerging or enlarging tumor. The software aligns and registers the two patient images to generate a difference image, which allows radiologists to pinpoint even subtle alterations that appear more clearly than on a conventional X-ray. Temporal Comparison also has received approval for marketing in the European Union.

In a study of 422 pairs of chest X-rays, 15 radiologists were able to show an average 12.4% improvement in sensitivity for actionable solitary pulmonary nodules using Riverain’s Temporal Comparison software as compared to results based on comparing the X-rays side by side, today’s standard (Riverain Medical DeltaView FDA 510(k) Reader Study Results 2011).

At present, clinicians position current and previous X-rays side by side to determine if there are changes in the lung tissue. Growths or infections appear as gradations of white, as do bones, the heart, and other structures, making it difficult to detect changes, particularly subtle ones.

Riverain’s Bone Suppression software removes the bones from the image, and then the Temporal Comparison software highlights changes between the two images, making any differences more obvious. “Lung tissue is very complex and it can be quite difficult to see changes, particularly in certain areas, such as the hilum and apices where vascular structures and bones come together,” said Steve Worrell, chief technology officer at Riverain. “The Temporal Comparison software is particularly helpful to radiologists in detecting changes in those areas.”

The combination of Riverain’s Bone Suppression and Temporal Comparison technologies also can be used with Riverain’s computer-aided detection (CAD) to improve early detection of lung disease.

Related Links:
Riverain Technologies


New
Gold Member
X-Ray QA Meter
T3 AD Pro
Fixed X-Ray System (RAD)
Allengers 325 - 525
Portable X-ray Unit
AJEX130HN
NMUS & MSK Ultrasound
InVisus Pro

Print article
Radcal

Channels

Radiography

view channel
Image: The new X-ray detector produces a high-quality radiograph (Photo courtesy of ACS Central Science 2024, DOI: https://doi.org/10.1021/acscentsci.4c01296)

Highly Sensitive, Foldable Detector to Make X-Rays Safer

X-rays are widely used in diagnostic testing and industrial monitoring, from dental checkups to airport luggage scans. However, these high-energy rays emit ionizing radiation, which can pose risks after... Read more

MRI

view channel
Image: Artificial intelligence models can be trained to distinguish brain tumors from healthy tissue (Photo courtesy of 123RF)

AI Can Distinguish Brain Tumors from Healthy Tissue

Researchers have made significant advancements in artificial intelligence (AI) for medical applications. AI holds particular promise in radiology, where delays in processing medical images can often postpone... Read more

Nuclear Medicine

view channel
Image: Example of AI analysis of PET/CT images (Photo courtesy of Academic Radiology; DOI: 10.1016/j.acra.2024.08.043)

AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer

Immunotherapy has significantly advanced the treatment of primary lung cancer, but it can sometimes lead to a severe side effect known as interstitial lung disease. This condition is characterized by lung... Read more

General/Advanced Imaging

view channel
Image: Cleerly offers an AI-enabled CCTA solution for personalized, precise and measurable assessment of plaque, stenosis and ischemia (Photo courtesy of Cleerly)

AI-Enabled Plaque Assessments Help Cardiologists Identify High-Risk CAD Patients

Groundbreaking research has shown that a non-invasive, artificial intelligence (AI)-based analysis of cardiac computed tomography (CT) can predict severe heart-related events in patients exhibiting symptoms... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.